Acute myocardial infarction in hospitalized patients with community-acquired pneumonia

Julio Ramirez1, Stefano Aliberti, Mehdi Mirsaeidi

  • 1Divisions of Infectious Diseases, University of Louisville and Veterans Administration, Louisville, Kentucky 40202, USA. j.ramirez@louisville.edu

Abstract

Insights

Acute myocardial infarction (AMI) is common in patients with severe community-acquired pneumonia (CAP). AMI should be considered when hospitalized CAP patients experience clinical failure, indicating a significant association.

Area of Science:

  • Cardiology
  • Pulmonology
  • Infectious Diseases

Background:

  • Epidemiological studies suggest a link between respiratory infections and acute myocardial infarction (AMI).
  • Recent data indicate an association between AMI and pneumococcal community-acquired pneumonia (CAP) in hospitalized patients.

Purpose of the Study:

  • To investigate the association between AMI and pneumonia severity at hospitalization.
  • To examine the association between AMI and clinical failure during hospitalization among CAP patients.

Main Methods:

  • Observational, retrospective study of 500 hospitalized CAP patients.
  • Severe CAP defined as ICU admission; clinical failure as respiratory failure or shock.
  • Propensity-adjusted models used to analyze associations between AMI, pneumonia severity, and clinical failure.

Main Results:

  • AMI was present in 15% of severe CAP patients at admission and 20% of those with clinical failure.
  • Significant associations were found between AMI and pneumonia severity index (P = .05).
  • Significant association was found between AMI and clinical failure (P = .04).

Conclusions:

  • Combined diagnosis of CAP and AMI is common in hospitalized patients with severe CAP.
  • AMI should be considered in hospitalized CAP patients experiencing clinical failure.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...